ANTEGRADE BALLOON VALVULOPLASTY OF SEVERE AORTIC STENOSIS IN NEONATES AND INFANTS  by Coe, James Y. et al.
    
  i2 SUMMIT   
E1997
JACC April 5, 2011
Volume 57, Issue 14
ANTEGRADE BALLOON VALVULOPLASTY OF SEVERE AORTIC STENOSIS IN NEONATES AND INFANTS
i2 Poster Contributions
Ernest N. Morial Convention Center, Hall F
Tuesday, April 05, 2011, 9:30 a.m.-10:45 a.m.
Session Title: PCI - Congenital, Structural, Valvular
Abstract Category: 14. PCI - Congenital, Pediatric and Structural Defects
Session-Poster Board Number: 2519-561
Authors: James Y. Coe, Prakul Chanthong, Dion Pepelassis, University of Alberta, Edmonton, Canada, University of Manitoba, Winnipeg, Canada
Background: Antegrade and retrograde transcatheter therapy of severe aortic stenoses (AS) in neonates and infants is widely accepted as the 
treatment of choice. This study examines the immediate results & outcome of the antegrade approach.
Methods: All procedures were performed under general anesthesia. Since November 1995, 47 neonates and infants underwent balloon 
valvuloplasty of their severe AS using a custom made balloon valvuloplasty catheter (CoEfficient, NuMed Inc., Hopkinton, N.Y.). The babies weighed 
1.2-9.1 (mean 4.3 ± 0.3, median 3.9) kg, and <1-179 (mean 37.6 ± 7.9, median 21) days old.
Results: There were no procedural or late deaths. Coarctation was repaired in 3 after balloon valvuloplasty, Ross procedure in 2, severe 
mitral regurgitation needing valve replacement in one, and heart transplant in two. By Doppler echocardiography, 12.5% did not have aortic 
regurgitation (AR), 12.5% had mild AR, 56.3% moderate AR, and 18.8% severe AR at the last clinic assessment. The peak systolic gradient (Doppler 
echocardiography) was 18-55 (mean 38.8 ± 3.9) mmHg, and the mean gradient 9-35 (mean 21.6 ± 2.6) mmHg.
Conclusions: Antegrade transcatheter balloon valvuloplasty of severe stenoses in neonates and infants is safe and effective. The tranvenous 
approach may permit the use of larger caliber ± balloon catheters. The outcome is favorable with no mortality to date.
